$26.340
-1.249 (-4.74%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de AMLX por análisis de gráficos similares
Alphio's AMLX stock price prediction model matches the current Amylyx Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $26.37 (+0.13%). The 1-week path is $27.02 (+2.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals Inc is currently not a strong buy due to its recent price decline and negative financial performance, despite a promising future with a current price of $26.34 and a forward P/E of 2.77. The stock has dropped 6.40% over the last five days and insiders have increased selling by 2291.45%, indicating potential caution. However, analyst targets suggest significant upside, with Guggenheim raising their target to $57, which reflects a potential increase of over 116% from the current price. The main risk is the company’s ongoing negative net income, which was -43,423,000 in Q2 2026, highlighting financial instability that could affect future performance.
AMLX cerró en $26.34 el Friday, tras bajar -4.74%
Amylyx Pharmaceuticals, Inc. (AMLX) last closed at $26.34, losing -4.74%. These facts feed the 1-day and 1-week AMLX price prediction above.
Factores de la previsión
Los factores de la previsión de Amylyx Pharmaceuticals, Inc. (AMLX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de AMLX, ordenadas por similitud.
Análisis de estacionalidad de AMLX
Historically the probability of a positive October return for AMLX is 60.34%. June offers the highest probability of a positive month at 68.33%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.